BioCentury

7:00 AM GMT, Sep 20, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Tysabri natalizumab: Post-marketing study data

As of Sept. 2, Biogen Idec said that there have been 68 confirmed cases of progressive multifocal leukoencephalopathy (PML) in patients

Read the full 217 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.